Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

321 ta ish

Ish: COVID-19 Vaccines - Current State and Perspectives

  1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

    Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97

    Maqola20203 iqtibos
    ABI

  2. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

    Tom T. Shimabukuro, Michael Nguyen, David Martin +1

    Sharh maqola20153 iqtibos
    ABI

  3. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes

    Dimitrios Karussis, Panayiota Petrou

    Sharh maqola20133 iqtibos
    ABI

  4. COVID-19 and Eye

    Mrittika Sen, Santosh G Honavar, Namrata Sharma +1

    Sharh maqola20213 iqtibos
    ABI

  5. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study

    Cristina Menni, Kerstin Kläser, Anna May +25

    Maqola20213 iqtibos
    ABI

  6. Sarlavhasiz

    Boshqa2 iqtibos
    ABI

  7. Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers

    Saghi Nooraei, Howra Bahrulolum, Zakieh Sadat Hoseini +4

    Sharh maqola20212 iqtibos
    ABI

  8. Vaccine hesitancy in the era of COVID-19

    Gianmarco Troiano, A Nardi

    Sharh maqola20212 iqtibos
    ABI

  9. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

    Julio S. Solís Arce, Shana S. Warren, Niccolò F. Meriggi +71

    Maqola20212 iqtibos
    ABI

  10. Circular RNA: metabolism, functions and interactions with proteins

    Zhou Wei-yi, Zerong Cai, Jia Liu +3

    Sharh maqola20202 iqtibos
    ABI

  11. Milk of Cow and Goat, Immunized by Recombinant Protein Vaccine ZF-UZ-VAC2001(Zifivax), Contains Neutralizing Antibodies Against SARS-CoV-2 and Remains Active After Standard Milk Pasteurization

    Victoria Garib, Stefani Katsamaki, Shahlo Тurdikulova +9

    MaqolaSARS-CoV-2 and COVID-19 ResearchFrontiers in Nutrition20222 iqtibos
    ABI

  12. A bacterial extracellular vesicle‐based intranasal vaccine against SARS‐CoV‐2 protects against disease and elicits neutralizing antibodies to wild‐type and Delta variants

    Linglei Jiang, Tom A. P. Driedonks, Wouter S. P. Jong +22

    Maqola20222 iqtibos
    ABI

  13. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions

    Carmen Schwechheimer, Meta Kuehn

    Sharh maqola20152 iqtibos
    ABI

  14. Direct Gene Transfer into Mouse Muscle in Vivo

    Jon A. Wolff, Robert W. Malone, Phillip Williams +4

    Maqola19902 iqtibos
    ABI

  15. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases

    Devon E. McMahon, Erin Amerson, Misha Rosenbach +11

    Maqola20212 iqtibos
    ABI

  16. Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

    Luca Spiro Santovito, Graziano Pinna

    Boshqa20212 iqtibos
    ABI

  17. The lightning-fast quest for COVID vaccines — and what it means for other diseases

    Philip Ball

    Maqola20202 iqtibos
    ABI

  18. Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi

    Steven Munharo, Symon Fidelis Nayupe, Patrick Mbulaje +6

    Maqola20202 iqtibos
    ABI

  19. Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future

    Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang +6

    Sharh maqola20222 iqtibos
    ABI

  20. Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It

    Zhipeng Yan, Ming Yang, Ching‐Lung Lai

    Maqola20222 iqtibos
    ABI

  21. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

    Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan +18

    Maqola20202 iqtibos
    ABI

  22. Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials

    Punam Mangtani, Ibrahim Abubakar, Cono Ariti +8

    Sharh maqola20132 iqtibos
    ABI

  23. A perspective on potential antibody-dependent enhancement of SARS-CoV-2

    Ann M. Arvin, Katja Fink, Michael Schmid +6

    Maqola20202 iqtibos
    ABI

  24. A vulnerability index for the management of and response to the COVID-19 epidemic in India: an ecological study

    Rajib Acharya, Akash Porwal

    Maqola20202 iqtibos
    ABI

  25. Vaccines for COVID-19

    John S. Tregoning, E. Sherwood Brown, Hannah M. Cheeseman +7

    Sharh maqola20202 iqtibos
    ABI